TY  - JOUR
AU  - Lee, Lucas D.
AU  - You, Y. Nancy
PY  - 2019
TI  - Perioperative safety in patients with resectable synchronous colorectal liver metastases
JF  - Chinese Clinical Oncology; Vol 8, Supplement 1 (October 22, 2019): Chinese Clinical Oncology
Y2  - 2019
KW  - 
N2  - Worldwide, at least a quarter of the patients with colorectal cancer (CRC) are diagnosed with metastatic disease at presentation and many of them eventually succumb to their disease. A third of these patients may have their metastatic disease burden confined to the liver. It has been estimated that about 15–25% of CRC patients initially present with synchronous resectable liver metastases (SRLM) (1). These patients represent a group whose oncologic prognosis has significantly improved over the past decades (2).
UR  - https://cco.amegroups.org/article/view/27598